Sinus headache: A clinical conundrum

Otolaryngologic Clinics of North America

Volumn 37, Issue 2, 2004, Pages 267-288

  Cady, Roger K ^a   Schreiber, Curtis P ^a  

^a HEADACHE CARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; STEROID; SUMATRIPTAN;

CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE SEVERITY; HEADACHE; HISTORY OF MEDICINE; HUMAN; INFLAMMATORY DISEASE; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; MIGRAINE; NOSE DISEASE; PARANASAL SINUS DISEASE; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICAL EXAMINATION; PHYSICIAN; POPULATION RESEARCH; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; RHINOSINUSITIS; RISK ASSESSMENT; RISK FACTOR; SINUS HEADACHE; SYMPTOM; UNITED STATES;

HEADACHE; HUMANS; PREVALENCE; SINUSITIS;

EID: 1842525722     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(03)00181-6     Document Type: Review

References (40)

1. Cady R.K., Schreiber C.P. Sinus or migraine? Considerations in making a differential diagnosis. Neurology. 58:(Suppl 6):2002;S10-S14.
2. Sheftell F., Dodick D., Cady R. Direct-to-consumer advertising of OTC agents under current FTC regulations: concerns and comments. Headache. 41:2001;534-536.
3. McBride P. Ueber die diagnose und behandlung der krankheiten der accessorischen hollen der nase. Deutch Med Wochenschr. 221:1891.
4. Sluder G. The role of the sphenopalatine ganglion in nasal headaches. New York Med J. 87:1908;989-990.
5. Wolff H.G. Headache and other pain. 1948;Oxford University Press, New York. p. 532-60.
6. McAuliffe G.W., Goodell H., Wolff H.G. Experimental studies on headache: pain from the nasal and paranasal structures. Res Publ Assoc Res Nerv Ment Dis. 23:1943;185-208.
7. Silberstein S.D., Wilcox T.O. Nasal disease and sinus headache. Silberstein S.D., Lipton R.B., Dalessio D.J. Wolff's headache and other head pain. 7th edition:2001;494-508 Oxford University Press, New York.
8. Couch J.R. Sinus headache: a neurologist's viewpoint. Semin Neurol. 8:1988;298-302.
9. Low W.K., Willatt D.J. Headaches associated with nasal obstruction due to deviated nasal septum. Headache. 35:1995;404-406.
10. Clerico D.M. Sinus headaches reconsidered: referred cephalgia of rhinological origin masquerading refractory primary headache. Headache. 35:1995;185-192.
11. Schonsted-Madsen U., Stoksted P., Christensen P.H., et al. Chronic headache related to nasal obstruction. J Laryngol Otol. 100:1986;165-170.
12. Tosun F., Gerek M., Ozkaptan Y. Nasal surgery for contact point headaches. Headache. 40:2000;237-240.
13. Headache Classification Committee of the International Headache Society. Classification of headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8:(Suppl 7):1988;1-96.
14. Wilson C.W.M., Kirker J.G., Warness H., et al. The clinical features of migraine as a manesfestation of allergy disease. Postgrad Med J. 56:1980;617-621.
15. Barbanti P., Fabbrini G., Perare M., et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia. 22:(40):2002;256-259.
16. Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia. 24:(Suppl 1):2004;118.
17. Lanza D.C., Kennedy D.W. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 117:1997;S1-S7.
18. Levine H.L. Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope. 100:1990;79-84.
19. Sheilds G., Seikaly H., LeBoeuf M., et al. Correlation between facial pain or headache and computed tomography in rhinosinusitis in Canadian and US subjects. Laryngoscope. 113:2003;943-945.
20. Lipton R.B., Stewart W.G., Dimond S., et al. Prevalence and burden of migraine in the US: data from the American Migraine Study II. Headache. 41:2001;646-657.
21. Cady K., Schreiber C. Sinus headache or migraine? Neurology. 58:(suppl 6):2002;S10-S14.
22. Which headache. A guide to the diagnosis and management of headache. 1991;Professional Postgraduate Services Europe Ltd. Worthing (UK).
23. Diamond M. The role of concomitant headache types and non-headache co-morbidities of migraine. Neurology. 58:(Suppl 6):2002;S3-S9.
24. Mansfield L.E., Vaughn T.R., Waller W.F. Food allergy and adult migraine, double blind and mediator confirmation of an allergic etiology. Ann Allergy. 55:1985;126-129.
25. Monro J., Carini C., Brostoff J. Migraine as a food-allergy disease. Lancet. 2:1984;719-721.
26. Lipton R.B., Stewart W.G., Cady R.K., et al. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum study. Headache. 40:2000;783-791.
27. Stempel. Rhinitis: what it means and why it matters. [discussion] Am J Manag Care. 8:(Suppl):1997.
28. Dalessio D.J. Wolff's headache and other head pain. 3rd edition:1972;Oxford University Press, New York.
29. Public Health Service. 1997. US Dept of Health and Human Services publication #93:1522.
30. Perry BF, Login IS, Kountakis SE. Non-rhinologic headache in tertiary rhinology practice [abstract]. Otolaryngol Head Neck Surg, in press.
31. Schreiber C.P., Hutchinson S., Webster C.J., et al. Prevalence of migraine among patients with a history of self-reported or physician diagnosed "sinus" headache. Arch Intern Med. 43:2003;. in press.
32. Ishkanian G, Blumenthal H, Powers C, et al. Sumatriptan is effective in migraine presenting as sinus headache. Poster Presentation at the Headache Update 2002. Orlando, July 16-20, 2002.
33. Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med. 325:1991;322-326.
34. White L.R., Sjaastad O. Sumatriptan and sensory neuropeptide activity in subarachnoid haemorrhage: an hypothesis. Cephalalgia. 15:1995;470-471.
35. Hargreaves R.J., Shepheard S.I. Pathophysiology of migraine-new insights. Can J Neurol Sci. 26:(Suppl 3):1999;S12-S19.
36. Goadsby P.J., Lipton R.B., Ferrari M.D. Migraine-current understanding and treatment. N Engl J Med. 346:2002;257-270.
37. Goadsby P.J., Edvinsson L., Ekman R. Release of vasoactive peptides in the extracellular circulation of man and cat during activation of the trigeminal vascular system. Ann Neurol. 23:1988;193-196.
38. Berger, Shoheiber O., Ledgerwood G.L., et al. New challenges to old standards in the treatment of rhinitis. J Manag Care Pharm. 7:(suppl):2001;1-16.
39. Bellamy JL, Cady RK, Schreiber CP, et al. Evaluation of CGRP and VIP as biological markers in activation of trigeminal and parasympathetic nerves in response to "sinus" symptoms. Poster Presentation, International Headache Society. Rome, Italy, September 13-16, 2003.
40. Meggs W.J. Neurogenic switching: a hypothesis for a mechanism for shifting site of inflammation in allergy and chemical sensitivity. Environ Health Perspect. 103:1995;54-56.